Medpace Holdings Inc vs MasTec Inc — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while MasTec Inc trades at $350.55 (market cap $26.60B). The key difference: MasTec Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| MEDP | MTZ | |
|---|---|---|
Market Cap | $15.08B | $26.60B |
Sector | Technology | Technology |
52-Week High | $620.59 | $437.51 |
52-Week Low | $308.88 | $172.51 |
Enterprise Value | $14.55B | $29.34B |
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →